On Friday, the Food and Drug Administration approved the first gene editing therapy ever to be used in humans, for sickle cell disease, a debilitating blood disorder caused by a single mutated gene. The agency also approved a second treatment using conventional gene therapy for sickle cell that does not use gene editing. For the […]
Read More